Meridian Bioscience (VIVO) Misses Street's Q2 Views; Lowers FY09 Outlook; Declares $0.17/Share Dividend
Tweet Send to a Friend
Meridian Bioscience (Nasdaq: VIVO) reports Q2 EPS of $0.18, 3 cents lower than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
